TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a TrialRohit Loomba, George Kemble, Robert S. Rahimi et al.|Gastroenterology|2021Cited by 216
The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) StudyChelsea Xu, Jennifer C. Lai, Yara Mohamad et al.|Liver International|2021Cited by 33
Cognitive Impairment and Physical Frailty in Patients With CirrhosisKacey Berry, Jennifer C. Lai, Andrés Duarte‐Rojo et al.|Hepatology Communications|2021Cited by 27